Literature DB >> 26523205

Dietary approach in the treatment of nonalcoholic fatty liver disease.

Silvia Marinho Ferolla1, Luciana Costa Silva1, Maria de Lourdes Abreu Ferrari1, Aloísio Sales da Cunha1, Flaviano Dos Santos Martins1, Cláudia Alves Couto1, Teresa Cristina Abreu Ferrari1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) has been identified as one of the most prevalent chronic liver disease in adults and children populations. NAFLD is usually associated with the metabolic syndrome (MS), which is chiefly related to insulin resistance and its consequences. Insulin resistance has a crucial role in the pathogenesis of hepatic steatosis and potentially nonalcoholic steatohepatitis (NASH). Because of the contemporary epidemics of MS and obesity, the burden of NAFLD is also expected to rise. Unhealthy diets, such as the so-called western diet, are enriched in fructose, trans-fatty acids and saturated fat and seem to be associated with the development of NAFLD. In human studies, certain dietary sugars, particularly fructose, are used as a substrate for lipogenesis leading to hepatic fatty infiltration, inflammation, and possibly fibrosis. Other investigations have shown that fat consumption especially cholesterol and trans/saturated fatty acids are also steatogenic and seem to increase visceral adiposity. The identification of specific dietary components that favor the development of NASH could be important for the management of this disorder. This review focuses on the effects of different dietary approaches to prevent and treat NAFLD emphasizing the macronutrients and energy composition.

Entities:  

Keywords:  Dietary carbohydrates; Dietary fats; Dietary fructose; Energy intake; Fatty liver

Year:  2015        PMID: 26523205      PMCID: PMC4621466          DOI: 10.4254/wjh.v7.i24.2522

Source DB:  PubMed          Journal:  World J Hepatol


  93 in total

1.  The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study.

Authors:  David Tendler; Sauyu Lin; William S Yancy; John Mavropoulos; Pam Sylvestre; Don C Rockey; Eric C Westman
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

2.  Dietary and physical activity patterns in children with fatty liver.

Authors:  D R Mager; C Patterson; S So; C D Rogenstein; L J Wykes; E A Roberts
Journal:  Eur J Clin Nutr       Date:  2010-03-10       Impact factor: 4.016

3.  Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease.

Authors:  Maria Cristina Elias; Edison Roberto Parise; Luciana de Carvalho; Denis Szejnfeld; João Prola Netto
Journal:  Nutrition       Date:  2009-12-22       Impact factor: 4.008

4.  Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

Authors:  Hellan Kang; Joel K Greenson; Jason T Omo; Cewin Chao; Debra Peterman; Lilian Anderson; Laura Foess-Wood; Mary A Sherbondy; Hari S Conjeevaram
Journal:  Am J Gastroenterol       Date:  2006-10       Impact factor: 10.864

5.  A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study.

Authors:  Valentina Volynets; Jürgen Machann; Markus A Küper; Ina B Maier; Astrid Spruss; Alfred Königsrainer; Stephan C Bischoff; Ina Bergheim
Journal:  Eur J Nutr       Date:  2012-04-28       Impact factor: 5.614

6.  Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults.

Authors:  Marno Celeste Ryan; Fahim Abbasi; Cindy Lamendola; Susan Carter; Tracey Lynn McLaughlin
Journal:  Diabetes Care       Date:  2007-03-10       Impact factor: 19.112

Review 7.  Diets and nonalcoholic fatty liver disease: the good and the bad.

Authors:  Mohamed Asrih; François R Jornayvaz
Journal:  Clin Nutr       Date:  2013-11-08       Impact factor: 7.324

8.  Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles.

Authors:  Stephen Bravo; Joshua Lowndes; Stephanie Sinnett; Zhiping Yu; James Rippe
Journal:  Appl Physiol Nutr Metab       Date:  2013-02-12       Impact factor: 2.665

Review 9.  Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD).

Authors:  Beth A Conlon; Jeannette M Beasley; Karin Aebersold; Sunil S Jhangiani; Judith Wylie-Rosett
Journal:  Nutrients       Date:  2013-10-11       Impact factor: 5.717

10.  No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men.

Authors:  Richard D Johnston; Mary C Stephenson; Hannah Crossland; Sally M Cordon; Elisa Palcidi; Eleanor F Cox; Moira A Taylor; Guruprasad P Aithal; Ian A Macdonald
Journal:  Gastroenterology       Date:  2013-07-19       Impact factor: 22.682

View more
  12 in total

1.  Summary of the 2016 Alcohol and Immunology Research Interest Group (AIRIG) meeting.

Authors:  Lisbeth A Boule; Cynthia Ju; Marisela Agudelo; Tiyash Parira; Abigail Cannon; Booker Davis; Jonathan Eby; Gail Cresci; Derrick R Samuelson; Pradeep Shukla; Waddah A Alrefai; Suhas Sureshchandra; Subhash C Pandey; Bernd Schnabl; Brenda J Curtis; Todd A Wyatt; Mashkoor A Choudhry; Elizabeth J Kovacs
Journal:  Alcohol       Date:  2017-09-23       Impact factor: 2.405

2.  High fat diet and exercise lead to a disrupted and pathogenic DNA methylome in mouse liver.

Authors:  Dan Zhou; Ryan A Hlady; Marissa J Schafer; Thomas A White; Chen Liu; Jeong-Hyeon Choi; Jordan D Miller; Lewis R Roberts; Nathan K LeBrasseur; Keith D Robertson
Journal:  Epigenetics       Date:  2016-11-18       Impact factor: 4.528

3.  Saturated fatty acid combined with lipopolysaccharide stimulates a strong inflammatory response in hepatocytes in vivo and in vitro.

Authors:  Yanchun Li; Zhongyang Lu; Ji Hyun Ru; Maria F Lopes-Virella; Timothy J Lyons; Yan Huang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-07-10       Impact factor: 4.310

Review 4.  Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Authors:  Donald B Jump; Kelli A Lytle; Christopher M Depner; Sasmita Tripathy
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

Review 5.  Non-alcoholic fatty liver disease in 2016.

Authors:  S A Townsend; Philip N Newsome
Journal:  Br Med Bull       Date:  2016-08-19       Impact factor: 4.291

Review 6.  Targeting Lifestyle Behavior Change in Adults with NAFLD During a 20-min Consultation: Summary of the Dietary and Exercise Literature.

Authors:  Kate Hallsworth; Leah Avery; Michael I Trenell
Journal:  Curr Gastroenterol Rep       Date:  2016-03

Review 7.  Industrial Trans Fatty Acid and Serum Cholesterol: The Allowable Dietary Level.

Authors:  Hiroyuki Takeuchi; Michihiro Sugano
Journal:  J Lipids       Date:  2017-08-30

8.  Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.

Authors:  Kelli A Lytle; Carmen P Wong; Donald B Jump
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

Review 9.  A systematic review of the present and future of non-alcoholic fatty liver disease.

Authors:  Christiana Lucas; Georgia Lucas; Nicholas Lucas; Joanna Krzowska-Firych; Krzysztof Tomasiewicz
Journal:  Clin Exp Hepatol       Date:  2018-09-10

Review 10.  Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression.

Authors:  Oren Tirosh
Journal:  Oxid Med Cell Longev       Date:  2018-05-31       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.